Ryman Healthcare

New Leadership And Pricing Reforms Will Boost Aged Care

AnalystConsensusTarget

Not Invested

Consensus Narrative from 4 Analysts

Published

22 Apr 25

Updated

15 Aug 25

AnalystConsensusTarget's Fair Value

NZ$2.83

11.5% undervalued

15 Aug

NZ$2.50

-49.9%

5.5%

Author's Valuation

NZ$2.8

11.5% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates1

Shared on01 May 25
Fair value Decreased 2.59%

AnalystConsensusTarget Fair Value

NZ$2.8

11.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

7.10%

Healthcare Services revenue growth rate

0.26%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.95%

Calculation

NZ$390.01m

Earnings '28

11.02x

PE Ratio '28

NZ$4.30b

Market Cap '28

NZ$4.30b

Market Cap '28

1.24b

No. shares '28

NZ$3.46

Share Price '28

NZ$3.46 Share Price '28

Discounted to 2025 @ 7.00% p.a.

NZ$2.82

Fair Value '25

New Leadership And Pricing Reforms Will Boost Aged Care

Shared on01 May 25Fair value Decreased 2.59%

Shared on01 May 25
Fair value Decreased 2.59%